Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

In the Literature

  • Article

    Antiplatelet Medications and the Risk of ICH in Patients with Metastatic Brain Tumors

    October 3, 2022

    Dr. Vaidyan Clinical question: Do antiplatelet medications increase the risk of intracranial hemorrhage (ICH) in patients with metastatic brain tumors?  Background: Brain metastases increase...

  • Article

    There is a Decreased Risk of Hospitalization from Heart Failure in Type II Diabetics Initiated on a SGLT2 Inhibitor When Compared to a GLP-1 Receptor Agonist

    September 1, 2022

    Dr. Huang Clinical question: Determine the cardiovascular risk outcome in type II diabetic patients initiated on an sodium-glucose cotransporter-2 (SGLT2)  inhibitor versus a glucagon-like...

  • Article

    Transthoracic Echocardiography is Superior in Detecting Valvular Heart Disease

    September 1, 2022

    Ms. Nowak Clinical question: To quantify the extent to which undetectable heart sounds occur in hospitalized patients who are undergoing transthoracic echocardiography and evaluate the...

  • Article

    Acute Care for the Elderly in the Home Environment Increased Physical Activity Levels While Lowering Costs, Health Care Use, and Readmissions

    September 1, 2022

    Dr. Nagaraj Clinical question: Can hospital-level care be provided in the home environment to reduce costs without compromising the quality of care in the U.S.? Background: Inpatient care is...

  • Article

    Mirtazapine is Not an Effective Treatment for Agitation in Dementia

    September 1, 2022

    Ms. Whalen CLINICAL QUESTION: What’s the clinical effectiveness and safety profile of mirtazapine in reducing agitation in dementia relative to placebo? BACKGROUND: Nonpharmacological...

  • Article

    Oral Antibiotics and a Combination Regimen of IV and Oral Antibiotics for Treatment of Acute Uncomplicated Appendicitis Yielded Similar Success Rates

    September 1, 2022

    Dr. Andleeb Clinical question: Are oral antibiotics effective and non-inferior to a combination of intravenous and oral antibiotics?  Background: Evidence over the past 10 years suggests that...

  • Article

    Low-dose Rivaroxaban at Discharge Prevented Some VTE Events at One Month for High-risk Patients Recovering from COVID-19

    September 1, 2022

    Dr. Thazhatuveetil-Kunhahamed Clinical Question: Is extended rivaroxaban prophylaxis (10 mg daily for 35 days) protective against arterial and venous thromboembolism (VTE) events in COVID-19...

  • Article

    The risk for intestinal necrosis with SPS is very low

    August 1, 2022

    Dr. Lippert Clinical question: What is the risk of intestinal necrosis with sodium polystyrene (SPS) for the treatment of hyperkalemia? Background: SPS is a medication that has been available...

  • Article

    Initiation of pulmonary rehabilitation after admission for COPD exacerbation decreases rehospitalizations

    August 1, 2022

    Ms. Langford Clinical question: Does the initiation of pulmonary rehabilitation after hospitalization for a chronic obstructive pulmonary disease (COPD) exacerbation impact...

  • Article

    Tranexamic acid minimized perioperative bleeding in patients undergoing noncardiac surgery

    August 1, 2022

    Dr. Menon Clinical question: Does tranexamic acid reduce the incidence of life-threatening perioperative bleeding in patients undergoing noncardiac surgery without increasing the risk of major...

Previous1 … 4 5 6 7 8 … 11Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences